REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 219 filers reported holding REATA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.91 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,190,900 | +471700.9% | 101,000 | +320.8% | 0.01% | +300.0% |
| Q1 2023 | $2,160 | -100.0% | 24,000 | +4.4% | 0.00% | -72.7% |
| Q4 2019 | $4,701,000 | +219.8% | 22,985 | +31.8% | 0.01% | +120.0% |
| Q3 2019 | $1,470,000 | -13.2% | 17,440 | -2.8% | 0.01% | +25.0% |
| Q2 2019 | $1,694,000 | +71.3% | 17,947 | +55.1% | 0.00% | +33.3% |
| Q1 2019 | $989,000 | – | 11,573 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 17,000 | $2,930 | 0.01% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 93,711 | $1,612 | 0.00% |
| IFP Advisors, Inc | 300 | $51,708 | 0.00% |